Application

15722408 · Compositions of Buprenorphine and µ AntagonistN

Filed 2017-10-02 · Granted · Patent 10188643 (2019-01-29) The official file ↗The patent and its PDF ↗ · Art unit 1629 · Examiner Kevin E Weddington Easy · CPC A61K 31/4748 · Alkermes Pharma Ireland Limited · Elmore Patent Law Group

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

7.2 mo

to disposition 15.9 mo

Statutes raised

112 DP

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.